According to Piper Sandler analysts, the initiative is set to ease regulatory uncertainties that have long deterred institutional players from entering or expanding in the digital asset market.

In a report released today, Derek Podhaizer from Piper Sandler maintained a Hold rating on NOV (NOV – Research Report), with a price target of $18.00. The company’s shares closed last Friday ...

Piper Sandler raised the firm’s price target on CNO Financial (CNO) to $46 from $44 and keeps an Overweight rating on the shares. The firm cites a strong quarter with more of the path of 50 bps ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The company’s shares closed last Friday at $293.54.

Piper Sandler raised the firm’s price target on Amgen (AMGN) to $329 from $310 and keeps an Overweight rating on the shares. The firm notes the PSC Biopharma Research team recently co-hosted its ...

Piper Sandler initiated coverage of Flowco (FLOC) with an Overweight rating and $34 price target Flowco is a pure-play North America provider of production optimization, artificial lift ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Idexx Laboratories (IDXX – Research Report) today and set a price target of $510.00. The company’s shares closed last Friday ...

Piper Sandler analyst Adam Maeder maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) today and set a price target of $233.00. The company’s shares closed last Friday ...

Shares of PINS opened at $40.02 on Friday. The business’s 50 day simple moving average is $31.43 and its 200-day simple moving average is $31.50. Pinterest has a one year low of $27.00 and a one ...

Piper Sandler analyst Christopher Raymond maintained a Buy rating on Abivax SA Sponsored ADR (ABVX – Research Report) today and set a price target of $42.00. The company’s shares closed last ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) today and set a price target of $40.00. The company’s shares closed last Friday at ...